Brady Family Wealth LLC Trims Stock Position in Danaher Corporation (NYSE:DHR)

Brady Family Wealth LLC cut its stake in Danaher Corporation (NYSE:DHR) by 14.7% in the 1st quarter, Holdings Channel reports. The firm owned 1,334 shares of the conglomerate’s stock after selling 229 shares during the period. Brady Family Wealth LLC’s holdings in Danaher were worth $274,000 at the end of the most recent quarter.

Other large investors have also recently modified their holdings of the company. FAS Wealth Partners Inc. raised its position in shares of Danaher by 20.6% in the 4th quarter. FAS Wealth Partners Inc. now owns 9,597 shares of the conglomerate’s stock worth $2,203,000 after acquiring an additional 1,639 shares in the last quarter. Charles Schwab Investment Management Inc. lifted its position in Danaher by 3.4% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 4,066,755 shares of the conglomerate’s stock valued at $933,524,000 after acquiring an additional 135,047 shares during the period. Camden National Bank grew its holdings in Danaher by 285.0% in the fourth quarter. Camden National Bank now owns 7,227 shares of the conglomerate’s stock worth $1,659,000 after purchasing an additional 5,350 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its stake in shares of Danaher by 11.4% during the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 5,677,032 shares of the conglomerate’s stock valued at $1,303,163,000 after purchasing an additional 579,046 shares in the last quarter. Finally, Dash Acquisitions Inc. increased its position in Danaher by 3.4% during the 4th quarter. Dash Acquisitions Inc. now owns 73,950 shares of the conglomerate’s stock valued at $18,328,000 after buying an additional 2,419 shares in the last quarter. Institutional investors own 79.05% of the company’s stock.

Analysts Set New Price Targets

Several equities research analysts have commented on the company. Deutsche Bank Aktiengesellschaft dropped their target price on Danaher from $240.00 to $235.00 in a report on Thursday, June 5th. Jefferies Financial Group cut their price objective on shares of Danaher from $260.00 to $230.00 and set a “buy” rating on the stock in a research report on Tuesday, April 22nd. Citigroup restated a “buy” rating on shares of Danaher in a research note on Monday, April 7th. Argus dropped their target price on shares of Danaher from $260.00 to $240.00 in a research note on Wednesday, April 23rd. Finally, UBS Group cut their price target on shares of Danaher from $275.00 to $240.00 and set a “buy” rating on the stock in a report on Wednesday, April 23rd. Five equities research analysts have rated the stock with a hold rating and sixteen have assigned a buy rating to the company. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $248.17.

Insider Activity at Danaher

In other Danaher news, Chairman Steven M. Rales sold 1,250,000 shares of the stock in a transaction that occurred on Monday, May 12th. The shares were sold at an average price of $196.74, for a total transaction of $245,925,000.00. Following the completion of the sale, the chairman now directly owns 3,105,808 shares of the company’s stock, valued at $611,036,665.92. This trade represents a 28.70% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, EVP Christopher Paul Riley sold 15,805 shares of the business’s stock in a transaction on Wednesday, April 30th. The stock was sold at an average price of $198.00, for a total transaction of $3,129,390.00. Following the completion of the transaction, the executive vice president now directly owns 15,179 shares in the company, valued at $3,005,442. This trade represents a 51.01% decrease in their position. The disclosure for this sale can be found here. 11.10% of the stock is owned by corporate insiders.

Danaher Price Performance

NYSE DHR opened at $194.36 on Friday. The business’s fifty day moving average is $193.74 and its 200 day moving average is $210.00. Danaher Corporation has a fifty-two week low of $171.00 and a fifty-two week high of $281.70. The company has a debt-to-equity ratio of 0.31, a quick ratio of 1.05 and a current ratio of 1.43. The company has a market capitalization of $139.10 billion, a PE ratio of 37.74, a price-to-earnings-growth ratio of 2.73 and a beta of 0.77.

Danaher (NYSE:DHR) last released its earnings results on Tuesday, April 22nd. The conglomerate reported $1.88 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.62 by $0.26. Danaher had a net margin of 15.81% and a return on equity of 10.80%. The company had revenue of $5.74 billion during the quarter, compared to analyst estimates of $5.58 billion. Sell-side analysts predict that Danaher Corporation will post 7.63 earnings per share for the current year.

Danaher Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, July 25th. Stockholders of record on Friday, June 27th will be given a dividend of $0.32 per share. This represents a $1.28 annualized dividend and a dividend yield of 0.66%. Danaher’s payout ratio is 24.85%.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.